Stage IV Anal Cancer Completed Phase 1 Trials for Trastuzumab (DB00072)

Also known as: Anal cancer stage IV / Anal carcinoma stage IV / Anal canal cancer stage IV

IndicationStatusPhase
DBCOND0028760 (Stage IV Anal Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004074Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuTreatment